(Q40609514)

22 September 2017

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines (English)

1 reference

22 September 2017

0 references

Shingo Dan

1

1 reference

22 September 2017

Mieko Shirakawa

2

1 reference

22 September 2017

Yumiko Mukai

3

1 reference

22 September 2017

Yoko Yoshida

4

1 reference

22 September 2017

Kanami Yamazaki

5

1 reference

22 September 2017

Tokuichi Kawaguchi

6

1 reference

22 September 2017

Masaaki Matsuura

7

1 reference

22 September 2017

Yusuke Nakamura

8

1 reference

22 September 2017

Takao Yamori

9

1 reference

22 September 2017

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

94

1 reference

22 September 2017

12

1 reference

22 September 2017

1074-1082

1 reference

describes a project that uses

22 September 2017

0 references

0 references

0 references

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Genome-based pharmacogenetics and the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Production of transforming growth factor-alpha in human tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Molecular targeting of mitomycin C chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Chemosensitivity prediction by transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Overexpression of aldose reductase in liver cancers may contribute to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing a redox imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Expression and the role of cathepsin H in human glioma progression and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01403.X

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/83.11.757

Identifiers

DOI

10.1111/J.1349-7006.2003.TB01403.X

1 reference

22 September 2017

1 reference